Physician profile
Arina Ghaffari
NPI 1467764274
$10,061.49
in general payments reported to CMS, 2019-2025
9 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,674 · 2020: $76.11 · 2024: $4,188 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $311.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,745.40 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $1,710.71 | 2019 | |
| Stryker Corporation | $432.53 | 2019-2025 | 1788, Spy-Phi System |
| Lifenet Health | $60.31 | 2024 | Theragenesis Wound Matrix |
| Conmed Corporation | $30.51 | 2025 | Airseal |
| Allergan, INC. | $28.71 | 2020 | |
| Coaptech, INC. | $18.37 | 2024 | Puma System |
| Solventum Corporation | $18.21 | 2025 | V.A.C.Ulta |
| Tela Bio, INC. | $16.74 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arina Ghaffari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.